跳转至内容
Merck
CN

33454

克拉维酸钾

VETRANAL®, analytical standard

别名:

棒酸钾

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C8H8NO5K
化学文摘社编号:
分子量:
237.25
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
262-640-9
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

克拉维酸钾, VETRANAL®, analytical standard

InChI key

ABVRVIZBZKUTMK-JSYANWSFSA-M

InChI

1S/C8H9NO5.K/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/q;+1/p-1/b4-1-;/t6-,7-;/m1./s1

SMILES string

[K+].[H][C@@]12CC(=O)N1[C@@H](C([O-])=O)C(\O2)=C\CO

grade

analytical standard

product line

VETRANAL®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

agriculture
clinical
environmental
forensics and toxicology
pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

该分析标准品可用于:
  • 利用毛细管电泳(CE)结合电容耦合非接触式电导检测法,对药物制剂中的阿莫西林和克拉维酸钾(C4D)同时进行分析
  • 建立一种稳定性指示的高效液相色谱(HPLC)法,并结合质谱(MS)技术,测定阿莫西林、克拉维酸钾及其杂质在其联合剂型中的含量
  • 使用紫外分光光度法对克拉维酸钾和阿莫西林三水合物在其原料药、联合片剂制剂和人类尿液样本中进行残留分析
  • 利用基于HPLC法的二极管阵列检测器(DAD),在静脉注射的同时测定美罗培南和克拉维酸钾及其降解杂质的含量
  • 利用毛细管区带电泳法(CZE),测定联合市售出制剂中阿莫西林和克拉维酸的含量

Biochem/physiol Actions

β-内酰胺酶抑制剂,通常加入阿莫西林以提高其功效。

General description

克拉维酸钾是奥沙那南的衍生物,属于β-内酰胺酶抑制剂。它可与青霉素类抗生素联合使用,使它们对β-内酰胺酶产生耐药性。

Other Notes

有关合适的仪器技术的更多信息,请参阅产品′的检验报告。想要获得更多支持,请联系技术服务部。

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

FlameHealth hazard

signalword

Danger

Hazard Classifications

Flam. Sol. 2 - Resp. Sens. 1 - Self-heat. 2 - Skin Sens. 1

supp_hazards

存储类别

4.2 - Pyrophoric and self-heating hazardous materials

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Dejenie Shiferaw Teklu et al.
Antimicrobial resistance and infection control, 8, 39-39 (2019-03-01)
The global emergence and spread of extended-spectrum beta-lactamases (ESBLs) producing Enterobacteriaceae have been threatening the ability to treat an infection. Hence, this study aimed to determine the prevalence of ESBL-producing and multi-drug resistance (MDR) Enterobacteriaceae (ESBLs-E) from different clinical specimens
David Baunoch et al.
Infection and drug resistance, 14, 3275-3286 (2021-08-28)
Studies have shown that multiple genes influence antibiotic susceptibility, but the relationship between genotypic and phenotypic antibiotic susceptibility is unclear. We sought to analyze the concordance between the presence of antibiotic resistance (ABR) genes and antibiotic susceptibility results in urine
Ximena Gonzalo et al.
The Journal of antimicrobial chemotherapy, 68(2), 366-369 (2012-10-17)
To: (i) assess if amoxicillin/clavulanate is a useful option for the management of multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB); (ii) assess if meropenem/clavulanate is active against Mycobacterium tuberculosis at concentrations achievable in vivo; and (iii) determine whether there was inhibition of meropenem/clavulanate
Oriol Mitjà et al.
The American journal of tropical medicine and hygiene, 86(6), 1043-1045 (2012-06-06)
We report the first documented case of a mycetoma caused by Nocardia yamanashiensis after the initial description of this species. The 16S-rRNA gene sequence analysis was used to identify the novel species, which showed a similarity of 99.9% to the
B R Smith et al.
Drug intelligence & clinical pharmacy, 19(6), 415-420 (1985-06-01)
Potassium clavulanate is a novel beta-lactamase inhibitor, which, in combination, expands the spectrum of amoxicillin to include many amoxicillin-resistant organisms. Potassium clavulanate is excreted 30-50 percent unchanged renally and its plasma time-course parallels that of amoxicillin. Several studies suggest that

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持